BTK and atrial fibrillation: However, more specific second‐generation BTKi also have an increased risk of atrial fibrillation and hypertension,18 suggesting that direct Bruton's tyrosine kinase inhibition may be relevant in the pathogenesis of atrial fibrillation and hypertension in humans.